Radiation response and survival time in patients with glioblastoma multiforme

Journal of Neurosurgery

Volumn 84, Issue 3, 1996, Pages 442-448

  Barker II, Fred G ^a,b   Prados, Michael D ^a   Chang, Susan M ^a   Gutin, Philip H ^a   Lamborn, Kathleen R ^a   Larson, David A ^a   Malec, Mary K ^a   Mcdermott, Michael W ^a   Sneed, Penny K ^a   Wara, William M ^a   Wilson, Charles B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

extent of resection; glioblastoma multiforme; prognosis; radiation response; survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; DOSE RESPONSE; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION RESPONSE; SURVIVAL RATE; SURVIVAL TIME;

EID: 13344293703     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.84.3.0442     Document Type: Article

References (45)

1. Albert FK, Forsting M, Sartor K, et al: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45-61, 1994
2. Allalunis-Turner MJ, Barron GM, Day RS III, et al: Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs. Radiat Res 134:349-354, 1993
3. Allam A, Taghian A, Gioioso D, et al: Intratumoral heterogeneity of malignant aliomas measured in vitro. Int J Radiat Oncol Biol Phys 27:303-308, 1993
4. Allen JC: The design and conduct of clinical trials in childhood brain tumors. Cancer 56:1827-1831, 1985
5. Anderson JR, Cain KC, Gelber RD: Analysis of survival by tumor response. J Clin Oncol 1:710-719, 1983
6. Barker FG, Prados MD, Chang SM, et al: Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age and survival. Int J Radiat Oncol Biol Phys (In press, 1996)
7. Byar DP, Green SB, Strike TA: Prognostic factors for malignant glioma, in Walker MD (ed): Oncology of the Nervous System. Boston: Martinus Nijhoff, 1983, pp 379-395
8. Cairncross JG, Macdonald DR, Pexman JHW, et al: Steroid-induced CT chanaes in patients with recurrent malignant glioma. Neurology 38:724-726, 1988
9. Chandler KL, Prados MD, Malec M, et al: Long-term survival in patients with glioblastoma multiforme. Neurosurgery 32: 716-720, 1993
10. Chang CH, Horton J, Schoenfeld D, et al: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the nmltidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 52: 997-1007, 1983
11. Cox DR: Regression models and Life tables. J R Stat Soc (B) 34:187-202, 1972
12. Davis RL: Grading of gliomas, in Fields WS (ed): Primary Brain Tumors. A Review of Histologic Classification. New York: Springer-Verlag, 1989, pp 151-158
13. Davis RL, Liu HC, Vestnys P, et al: Correlation of survival and diagnosis in supratentorial malignant gliomas. J Neurooncol 2:267, 1984 (Abstract)
14. Devaux BC, O'Fallon JR, Kelly PJ: Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 78: 767-775, 1993
15. Dinapoli RP, Brown LD, Arusell RM, et al: Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma. J Clin Oncol 11: 1316-1321, 1993
16. Duncan GG, Goodman GB, Ludgate CM, et al: The treatment of adult supratentorial high grade astrocytomas. J Neurooncol 13:63-72, 1992
17. Finlay JL, Geyer JR, Turski PA, et al: Pre-irradiation chemotherapy in children with high-grade astrocytoma: tumor response to two cycles of the '8-drugs-in-1-day' regimen. A Childrens Cancer Group study, CCG-945. J Neurooncol 21: 255-265, 1994
18. Forsting M, Albert FK, Kunze S, et al: Extirpation of glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns. AJNR 14:77-87, 1993
19. Franklin CIV: Does the extent of surgery make a difference in high grade malignant astrocytoma? Australas Radiol 36: 44-47, 1992
20. Gaspar LE, Fisher BJ, MacDonald DR, et al: Malignant glioma - timing of response to radiation therapy. Int J Radiat Oncol Biol Phys 25:877-879, 1993
21. Gehan EA, Walker MD: Prognostic factors for patients with brain tumors. Natl Cancer Inst Monogr 46:189-195, 1977
22. Green SB, Byar DP, Walker MD, et al: Comparisons of carmustine, procarbazine, and high-dose methylprednisotone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67:121-132, 1983
23. Harris EK, Albert A: Survivorship Analysis for Clinical Studies. New York: Marcel Dekker, 1991
24. Kleihues P, Burger PC, Scheithauer BW: Histologic Typing of Tumours of the Central Nervous System, ed 2. Berlin: Springer-Verlag, 1993
25. Kreth FW, Warnke PC, Scheremet R, et al: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78: 762-766, 1993
26. Krouwer HGJ, Prados MD: Infiltrative astrocytomas of the thalamus. J Neurosurg 82:548-557, 1995
27. Kumabe T, Kayama T, Yoshimoto T, et al: [Follow-up study of malignant astrocytomas showing complete response after initial treatment.] No Shinkei Geka 22:545-551, 1994 (Jpn)
28. Laohaprasit V, Silbergeld DL, Ojemann GA, et al: Postoperative CT contrast enhancement following lobectomy for epilepsy. J Neurosurg 73:392-395, 1990
29. Lee ET: Statistical Methods for Survival Data Analysis, ed 2. New York: John Wiley & Sons, 1992
30. Levin VA, Prados MD, Yung WKA, et al: Treatment of recurrent gliomas with eflornithine. J Natl Cancer Inst 84: 1432-1437, 1992
31. Macdonald DR, Cascino TL, Schold SC Jr, et al: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280, 1990
32. Medical Research Council Brain Tumour Working Party: Prognostic factors for high-grade malignant glioma: development of a prognostic index. J Neurooncol 9:47-55, 1990
33. Murovic J, Turowski K, Wilson CB, et al: Computerized tomography in the prognosis of malignant cerebral gliomas. J Neurosurg 65:799-806, 1986
34. Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73:331-344, 1990
35. Shapiro WR, Green SB, Burger PC, et al: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71:1-9, 1989
36. Simpson JR, Horton J, Scott C, et al: Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26:239-244, 1993
37. Taghian A, Ramsay J, Allalunis-Turner J, et al: Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 25:243-249, 1993
38. Walker MD, Alexander E Jr, Hunt WE, et al: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49:333-343, 1978
39. Walker MD, Green SB, Byar DP, et al: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323-1329, 1980
40. Watling CJ, Lee DH, Macdonald DR, et al: Corticosteroid-induced magnetic resonance imaging changes in patient with recurrent malignant glioma. J Clin Oncol 12:1886-1889, 1994
41. Weiss GB, Bunce H III, Hokanson JA: Comparing survival of responders and nonresponders after treatment: a potential source of confusion in interpreting cancer clinical trials. Controlled Clin Trials 4:43-52, 1983
42. Winger MJ, Macdonald DR, Cairncross JG: Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71:487-493, 1989
43. Wood JR, Green SB, Shapiro WR: The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 6:338-343, 1988
44. Yamada S, Takai Y, Nemoto K, et al: Radioresponse and prognosis of malignant glioma. Tohoku J Exp Med 167:79-87, 1992
45. Zeltzer PM, Friedman HS, Norris DG, et al: Criteria and definitions for response and relapse in children with brain tumors. Cancer 56:1824-1826, 1985